Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 834 $ 904
Restricted cash and cash equivalents 160 92
Trade and other receivables, net of current expected credit losses 269 627
Trade receivables—affiliate 263 551
Advances to affiliate 157 177
Inventory 150 160
Current derivative assets 55 24
Margin deposits 0 35
Other current assets 44 50
Other current assets—affiliate 1 0
Total current assets 1,933 2,620
Property, Plant and Equipment, Net 16,587 16,725
Operating lease assets 87 89
Debt issuance costs, net of accumulated amortization 7 8
Derivative assets 32 28
Other non-current assets, net 171 163
Total assets 18,817 19,633
Current liabilities    
Accounts payable 70 32
Accrued liabilities 674 1,378
Accrued liabilities—related party 5 6
Current debt, net of discount and debt issuance costs 60 0
Due to affiliates 32 74
Deferred revenue 83 144
Deferred revenue—affiliate 0 3
Current operating lease liabilities 11 10
Current derivative liabilities 400 769
Other current liabilities 13 5
Total current liabilities 1,348 2,421
Long-term debt, net of premium, discount and debt issuance costs 16,145 16,198
Operating lease liabilities 78 80
Finance lease liabilities 17 18
Derivative liabilities 2,157 3,024
Other non-current liabilities—affiliate 22 23
Partners’ deficit    
Common unitholders’ interest (484.0 million units issued and outstanding at both March 31, 2023 and December 31, 2022) 261 (1,118)
General partner’s interest (2% interest with 9.9 million units issued and outstanding at both March 31, 2023 and December 31, 2022) (1,211) (1,013)
Total partners’ deficit (950) (2,131)
Total liabilities and partners’ deficit $ 18,817 $ 19,633